Advertisement

Nasopharyngeal Carcinoma

  • G. de-Thé
  • J. H. C. Ho
  • C. S. Muir

Abstract

Nasopharyngeal carcinoma (NPC) and Burkitt lymphoma (BL) are neoplasms for which there is strong evidence of a viral association. Their study exemplifies the problems inherent in chronic-disease epidemiology and in demonstrating a causal relationship between viruses and cancer in man. (42a)

Keywords

Nasopharyngeal Carcinoma Infectious Mononucleosis Nasopharyngeal Cancer Salted Fish Sopharyngeal Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ali, M. Y., and Shanmugaratnam, K., Cytodiagnosis of nasopharyngeal carcinoma, Acta Cytol. 11: 51–60 (1967).Google Scholar
  2. 2.
    Anderson, E. N., Jr., Anderson, M. L., and Ho, J. H. C., A study of the environmental backgrounds of young Chinese nasopharyngeal carcinoma patients, in: Nasopharyngeal Carcinoma: Etiology and Control (G. De-Thé and Y. Ito, eds.), pp. 231–239, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  3. 3.
    Andersson-Anvret, M., Forsby, N., Klein, G., and Henle, W., Studies on the occurrence of Epstein-Barr virus DNA in nasopharyngeal carcinomas in comparison with tumors of other head and neck regions, Int. J. Cancer 20: 702–707 (1977).Google Scholar
  4. 4.
    Andersson-Anvret, M., Forsby, N., Klein, G., and HENLE, W., The association between undifferentiated nasopharyngeal carcinoma and Epstein-Barr virus shown by correlated nucleic acid hybridization and histopathological studies, in: Nasopharyngeal Carcinoma: Etiology and Control (G. De-Thé Andy. Ito, eds.), pp. 347–358, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  5. 5.
    Andrews, P. A. I., and Michaels, I., Nasopharyngeal carcinoma in Canadian bush pilots, and aviator’s cancer, Lancet 2: 85, 640 (1968).PubMedGoogle Scholar
  6. 6.
    Armstrong, R. W., Kannan-Kutty, M., and Arm-Strong, M. J., Self-specific environments associated with nasopharyngeal carcinoma in Selangor, Malaysia, Soc. Sci. Med. 12: 149–156 (1978).PubMedGoogle Scholar
  7. 7.
    Aya, T., and Osato, T., Early events in transformation of human cord leukocytes by Epstein-Barr virus: Induction of DNA synthesis, mitosis and the virus associated nuclear antigen synthesis, Int. J. Cancer 14: 341–347 (1974).PubMedGoogle Scholar
  8. 8.
    Bailar, J. C., III, Race, environment and family in the epidemiology of cancer of the nasopharynx, in: Cancer of the Nasopharynx (C. S. MUIR and K. Shanmugaratnam, eds.), pp. 101–105, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  9. 9.
    Benyesh-Melnick, M., Fernbarch, D. J., and Lewis, R. T., Studies on human leukemia. I. Spontaneous lymphoblastoid transformation of fibroblastic bone marrow cultures derived from leukemic and non-leukemic children, J. Natl. Cancer Inst. 31: 1311–1331 (1963).PubMedGoogle Scholar
  10. 10.
    Betuel, H., Cammoun, M., Colombani, J., Day, N. E., Ellouz, R., and De-Thé, G., The relationship be- tween nasopharyngeal carcinoma and the HL-A sys- tem among Tunisians, Int. J. Cancer 16: 249–254 (1975).PubMedGoogle Scholar
  11. 11.
    Bjarnason, O., Day, N., Snaedal, G., and Tulinius, H., The effect of year on the breast cancer age incidence curve in Iceland, Int. J. Cancer 13: 689–696 (1974).PubMedGoogle Scholar
  12. 12.
    Blot, W. J., Lanier, A., and Fraumeni, J. F., Jiz., Cancer mortaliy among Alaskan natives 1960–1969, J. Natl. Cancer Inst. 55: 547–554 (1975).PubMedGoogle Scholar
  13. 13.
    Buell, P., Nasopharyngeal cancer in Chinese of California, Br. J. Cancer 19: 459–470 (1965).PubMedGoogle Scholar
  14. 14.
    Buell, P., Race and place in the etiology of naso-pharyngeal cancer: A study based on California death certificates, Int. J. Cancer 11: 268–272 (1973).PubMedGoogle Scholar
  15. 15.
    Burkitt, D. P., The trail to a virus, in: Oncogenesis and Herpesviruses (P. M. BIGGS, G. DE-THÉ, and L. N. PAYNE, eds.), pp. 345–348, IARC Scientific Publication No. 2, Lyon, France, 1972.Google Scholar
  16. 16.
    Cammoun, M., Vogt-Hoerner, G., and Mourali, N., Les tumeurs du naso-pharynx en Tunisie: Étude anatomo-clinique de 143 observations, Tunis Med. 49 (3): 131–141 (1971).Google Scholar
  17. 17.
    Chan, S. H., Chew, T. S., Goh, E. H., Simons, M. J., and Shanmugaratnam, K., Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma, Int. J. Cancer 18 (2): 139–144, (1976).PubMedGoogle Scholar
  18. 18.
    Churchill, A. E., Payne, L. N., and Chubb, R. C., Immunization against Marek’s disease using a live attenuated virus, Nature (London) 221: 744–747 (1969).Google Scholar
  19. 19.
    Clifford, P., Carcinoma of the nasopharynx in Kenya, East Afr. Med. J. 42: 373–396 (1965).PubMedGoogle Scholar
  20. 20.
    Clifford, P., Malignant diseases of the nasopharynx and paranasal sinuses in Kenya, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 82–94, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  21. 21.
    Clifford, P., A review on the epidemiology of nasopharyngeal carcinoma, Int. J. Cancer 5: 287–309 (1970).PubMedGoogle Scholar
  22. 22.
    Clifford, P., Carcinogens in the nose and throat: Nasopharyngeal carcinoma in Kenya, Proc. R. Soc. Med. 65: 682–686 (1972).PubMedGoogle Scholar
  23. 23.
    Derry, D. E., Anatomical report (B), in: Archaeological Survey of Nubia, Cairo, Egyptian Ministry of Finance (Bulletin No. 3), pp. 40–42, 1909.Google Scholar
  24. 24.
    Schryver, A., Friberg, S., JR., Klein, G., Henle, W., Henle, G., De-Thé, G., Clifford, P., and Ho, H. C., Epstein-Barr associated antibody patterns in carcinoma of the post-nasal space, Clin. Exp. Immunol. 5: 443–459 (1969).PubMedGoogle Scholar
  25. 25.
    Schryver, A., Klein, G., Henle, G., Henle, W., Cameron, H., Santesson, L., and Clifford, P., Ep-stein-Barr virus associated serology in malignant disease: Antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens (EA) in patients with various neoplastic conditions, Int. J. Cancer 9: 353–364 (1972).PubMedGoogle Scholar
  26. 26.
    Desgranges, C., Wolf, H., De-Thé, G., Shanmugaratnam, K., Ellouz, R., Cammoun, N., Klein, G., and Hausen, H., Nasopharyngeal carcinoma X-Presence of Epstein-Barr genomes in epithelial cells of tumours from high and medium risk areas, Int. J. Cancer 16: 7–15 (1975).PubMedGoogle Scholar
  27. 27.
    Desgranges, C., De-Thé, G., Ho, J. H. C., and Ellouz, R., Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients, Int. J. Cancer 19: 627–633 (1977).PubMedGoogle Scholar
  28. 28.
    Desgranges, C., Li, J. Y., and De-Thé, G., EBV specific secretory IgA in saliva of NPC patients: Presence of secretory piece in epithelial malignant cells, Int. J. Cancer 20: 881–886 (1977).PubMedGoogle Scholar
  29. 29.
    Desgranges, C., and De-Thé, G., Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: Their activity, origin, and possible clinical value, in: Nasopharyngeal Carcinoma: Etiology and Control (G. De-Thé and Y. Ito, eds.), pp. 459–469, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  30. 30.
    De-Thé, G., Ambrosioni, J. C., Ho, H. C., and Kwan, H. C., Lymphoblastoid transformation and presence of herpes-types viral particles in a Chinese naso-pharyngeal tumour cultured in vitro, Nature (London) 221: 770–771 (1969).Google Scholar
  31. 31.
    De-Thé, G., Ho, H. C., Kwan, H. C., Desgranges, C., and Favre, M. C., Nasopharyngeal carcinoma (NPC). I. Types of cultures derived from tumour biopsies and non-tumorous tissues of Chinese patients with special reference to lymphoblastoid transformation, Int. J. Cancer 6: 189–206 (1970).PubMedGoogle Scholar
  32. 32.
    De-Thé, G., Geser, A., Day, N. E., Tukei, P. M., Williams, E. H., Beri, D. P., Smith, P. G., Dean A. G., Bornkamm, G. W., Feorino, R., and Henle, W., Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study, Nature 274: 756–761 (1978).PubMedGoogle Scholar
  33. 33.
    De-Thé, G., Sohier, R., Ho, J. H. C., and Freund, R., Nasopharyngeal carcinoma. IV. Evolution of complement fixing antibodies during the course of the disease, Int. J. Cancer 12: 368–377 (1973).PubMedGoogle Scholar
  34. 34.
    De-Thé, G., Ablashi, D. V., Liabeuf, A., and Mourali, N., Nasopharyngeal carcinoma (NPC). VI. Pres- ence of an EBV nuclear antigen in fresh tumour biop- sies: Preliminary results, Biomedicine 19: 349–352 (1973).PubMedGoogle Scholar
  35. 35.
    De-Thé, G., Desgranges, C., Zeng, Y., Wang, P. C., Bornkamm, G. W., Zhu, J. S. and Shang, M., Search for pre-cancerous lesions and EBV markers in the Nasopharynx of IgA positive individuals, in: Naso-pharyngeal Carcinoma, Cancer Campaign, Vol. 5, (Grundmann, E., Krueger, G. R. F., Ablash, D. V., eds.), pp. 111–117, Gustav Fisher Verlag, Stuttgart, 1981.Google Scholar
  36. 36.
    De-Thé, G., Day, N. E., Geser, A., Ho, J. H. C., Lavoue, M. F., Simons, M. J., Sohier, R., and Tukei, P., Epidemiology of the Epstein-Barr virus: Preliminary analysis of an international study, in: Oncogenesis and Herpesviruses II (G. De-Thé, M. A. Epstein, and H. Zur Hausen, eds.), pp. 3–16, IARC Scientific Publication No. 11, Vol. 2, IARC, Lyon, France, 1975.Google Scholar
  37. 37.
    De-Thé, G., Ho, J. H. C., Ablashi, D. V., Day, N. E., Macario, A. J. L., Martin-Berthelon, M. C., Pear-Son, G., and Sohier, R., Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other EBV antigens in Chinese patients, Int. J. Cancer 16: 713–721 (1975).PubMedGoogle Scholar
  38. 38.
    De-Thé, G., Vuillaume, M., Giovanella, B. C., and Klein, G., Epithelial characteristics of tumour cells in nasopharyngeal carcinoma (NPC) passaged in nude mice-an ultrastructural study, J. Natl. Cancer Inst. 57: 1101–1105 (1976).PubMedGoogle Scholar
  39. 39.
    De-Thé, G., Is Burkitt’s lymphoma (BL) related to a perinatal infection by Epstein-Barr virus?, Lancet 1: 335–338 (1977).PubMedGoogle Scholar
  40. 39a.
    De-Thé, G., Epstein-Barr virus: Is it time to discuss a vaccine? Biomed. Comm. 28: 15–17 (1978).Google Scholar
  41. 40.
    De-Thé, G., Lavoué, M.-F., and Muenz, L., Differences in EBV antibody titres of patients with naso-pharyngeal carcinoma originating from high, intermediate and low incidence areas, in: Nasopharyngeal Carcinoma: Etiology and Control (G. De-Thé and Y. ITo, eds.), pp. 471–481, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  42. 41.
    De-Thé, G., The epidemiology of Burkitt’s lymphoma: Evidence for a causal association with Epstein-Barr virus-a review, Am. J. Epidemiol. 1: 32–57 (1979).Google Scholar
  43. 41.
    De-Thé, G., The epidemiology of Burkitt’s lymphoma: Evidence for a causal association with Epstein-Barr virus-a review, Am. J. Epidemiol. 1: 32–57 (1979).Google Scholar
  44. 42a.
    De-Thé, G., Multistep carcinogenesis, Epstein-Barr virus and human malignancies, in: Viruses in Naturally Occurring Cancers (M. Essex, G. Todaro, H. Zur Hausen, eds.), pp. 11–21, Cold Spring Harbor Conferences on Cell Proligeration, Vol. 7, Cold Spring Harbor Laboratory Publ., Cold Spring Harbor, New York, 1980.Google Scholar
  45. 43.
    Digby, K. H., Thomas, G. H., and Hsiu, S. T., Notes on carcinoma of the nasopharynx, Caduceus 9: 45–64 (1930).Google Scholar
  46. 44.
    Dobson, W. C., Cervical lymphosarcoma (letter to the editor), Chin. Med. J. 38: 786 (1924).Google Scholar
  47. 45.
    Doll, R., Epidemiology of cancer: Current perspectives, Am. J. Epidemiol. 104: 396–408 (1976).PubMedGoogle Scholar
  48. 46.
    Durand-Fardel, Cancer du pharynx-ossification dans la substance musculaire du coeur, Bull. Soc. Anat. (Paris) 12: 73–80 (1837).Google Scholar
  49. 47.
    Epstein, M. A., Achong, B. G., and Barr, Y. M., Virus particles in cultured lymphoblaste from Burkitt’s lymphoma, Lancet 1: 702–703 (1964).PubMedGoogle Scholar
  50. 48.
    Epstein, M. A., and Achong, B. G., Recent progress in EB virus research, Annu. Rev. Microbiol. (1977).Google Scholar
  51. 49.
    Evans, A. S., and Niederman, J. C., Epidemiology of infectious mononucleosis, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. De-Thé, and L. N. Payne, eds.), pp. 351–356, IARC Scientific Publications No. 2, Lyon, France, 1972.Google Scholar
  52. 50.
    Evans, A. S., The history of infectious mononucleosis, Am. J. Med. Sci. 267: 189 (1974).PubMedGoogle Scholar
  53. 51.
    Evans, A. S., New discoveries in infectious mononucleosis, Mod. Med. 1: 18–24 (1974).Google Scholar
  54. 52.
    Fong, Y. Y., and Walsh, E. O., Carcinogenic nitrosamines in Cantonese salt-dried fish, Lancet 1: 1032 (1971).Google Scholar
  55. 53.
    Fong, Y. Y., and Chan, W. C., Bacterial production of di-methyl nitrosamine in salted fish, Nature (London) 243: 421–422 (1973).Google Scholar
  56. 54.
    Fraumeni, J. F., JR., and Mason, T. J., Cancer mortality among Chinese Americans, 1950–69, J. Natl. Cancer Inst. 52: 659–665 (1974).PubMedGoogle Scholar
  57. 55.
    Gallo, R. C., Saxinger, W. C., Gallagher, R. E., Gillespie, D. A., Aulakh, G. S., and Wong-Staal, F., Some ideas on the origin of leukemia in man and recent evidence for the presence of type-C viral re- lated information, in: Origins of Human Cancer (H. Hiatt, J. D. Watson, and J. A. Winsten, eds.), pp. 1253–1285, Cold Spring Harbor Conferences on Cell Proliferation, Vol. 4, Book B, Cold Spring Harbor Publ., Cold Spring Harbor, New York, 1977.Google Scholar
  58. 56.
    Gazzolo, L., De-Thé, G., and Vuillaume, M., Nasopharyngeal carcinoma. II. Ultrastructure of normal mucosa, tumor biopsies and subsequent epithelial growth in vitro, J. Natl. Cancer Inst. 48: 73–86 (1972).PubMedGoogle Scholar
  59. 57.
    Gerber, P., and Birch, S., Complement-fixing antibodies in sera of human and non-human primates to viral antigens derived from Burkitt’s lymphoma cells, Proc. Natl. Acad. Sci. U.S.A. 58: 478–484 (1967).PubMedGoogle Scholar
  60. 58.
    Gerber, P., Whang-Peng, J., and Monroe, J., Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures, Proc. Natl. Acad. Sci. U.S.A. 63: 740–747 (1969).Google Scholar
  61. 59.
    Gerber, P., Nonoyama, M., Lucas, S., Perlin, E., and Goldstein, L., Oral excretion of EBV by healthy subjects and patients with infectious mononucleosis, Lancet 2: 988–989 (1972).PubMedGoogle Scholar
  62. 60.
    Geser, A., Day, N. E., De-Thé, G., Chew, T. S., Freund, R. J., Kwan, H. C., Lavoué„ M. F., Simkovic, D., and Sohier, R., The variability in immunofluorescent viral capsid antigen antibody testing in population surveys of Epstein-Barr virus infection, Bull WHO 50: 389–400 (1974).PubMedGoogle Scholar
  63. 61.
    Geser, A., Charnay, N., Day, N. E., De-Thé, G., and Ho, H. C., Environmental factors in the etiology of nasopharyngeal carcinoma: Report on a case-control study in Hong Kong, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ and Y. ITO, eds.), pp. 213–229, IARC Scientific Publication No. 20, Lyon, France, 1978.Google Scholar
  64. 62.
    Glaser, R., De-Thé, G., Lenoir, G., and Ho, J. H. C., Superinfection of nasopharyngeal carcinoma epithelial tumour cells with Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 73: 960–963 (1976).PubMedGoogle Scholar
  65. 63.
    Green, M. H., Fraumeni, J. F., JR., and Hoover, R., Nasopharyngeal cancer among youngs in United States: Racial variations by cell type, J. Natl. Cancer Inst. 58: 1267–1270 (1977).Google Scholar
  66. 64.
    Hawkins, B. R., Simons, M. J., Goh, E. H., Chia, K. B., and Shanmugaratnam, K., Immunogenetic aspects of nasopharyngeal carcinoma. II. Analysis of ABO, Rhesus and MNS’s red cell systems, Int. J. Cancer 13: 116–121 (1974).PubMedGoogle Scholar
  67. 65.
    Henderson, B. E., Louie, E., Jing, J. S. H., Buell, P., and Gardner, M. B., Risk factors associated with nasopharyngeal carcinoma, N. Engl. J. Med. 295: 1101–1106 (1976).PubMedGoogle Scholar
  68. 66.
    Henderson, B. E., and Louie, E., Discussion of risk factors for nasopharyngeal carcinoma, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ and Y. ITO, eds.), pp. 251–260, IARC Scientific Publication No. 20, Lyon, France, 1978.Google Scholar
  69. 67.
    Henle, G., and Henle, W., Immunofluorescence in cells derived from Burkitt’s lymphoma, J. Bacteriol. 91: 1248–1256 (1966).PubMedGoogle Scholar
  70. 68.
    Henle, W., Henle, G., Burtin, P., Cachin, Y., Clifford, P., de Schryver, A., De-Thé, G., Diehl, V., Ho, H. C., and Klein, G., Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and control groups, J. Natl. Cancer Inst. 44: 225–231 (1970).PubMedGoogle Scholar
  71. 69.
    Henle, W., Henle, G., Zajac, B. A., Pearson, G., Waubke, R., and Scriba, M., Differential reactivity of human serums with early antigens induced by Epstein-Barr virus, Science 169: 188–190 (1970).PubMedGoogle Scholar
  72. 70.
    Henle, G., Henle, W., and Klein, G., Demonstration of two distinct components in the early antigen complex of EBV infected cells, Int. J. Cancer 8: 272–282 (1971).PubMedGoogle Scholar
  73. 71.
    Henle, G., Antibodies to EBV-induced early antigens in infectious mononucleosis, Burkitt’s lymphoma and nasopharyngeal carcinoma, in: Recent Advances in Human Tumor Virology and Immunology (W. Nakahara, K. Nishioka, T. Hirayama, and T. ITo, eds.), pp. 343–359, University of Tokyo Press, Tokyo, 1971.Google Scholar
  74. 72.
    Henle, W., and Henle, G., Epstein-Barr virus: The cause of infectious mononucleosis, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. De-Thé, and L. N. Payne, eds.), pp. 358–370, IARC Scientific Publication No. 2, Lyon, France, 1972.Google Scholar
  75. 73.
    Henle, W., and Henle, G., Epstein-Barr virus and infectious mononucleosis, N. Engl. J. Med. 288: 263–264 (1973).PubMedGoogle Scholar
  76. 74.
    Henle, W., Ho, H. C., and Kwan, H. C., Antibodies to Epstein-Barr virus related antigens in nasopharyngeal carcinoma: Comparison of active cases with long term survivors, J. Natl. Cancer Inst. 51: 361–369 (1973).PubMedGoogle Scholar
  77. 75.
    Henle, G., and Henle, W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma, Int. J. Cancer 17: 1–7 (1976).PubMedGoogle Scholar
  78. 76.
    Higginson, J., De-Thé, G., Geser, A., and Day, N. E., An epidemiological analysis of cancer vaccines, Int. J. Cancer 7: 565–574 (1971).PubMedGoogle Scholar
  79. 77.
    Higginson, J., and Maclennan, R., The world pattern of cancer incidence, in: Modern Trends in Oncology-Research Progress (R. W. Raven, ed.), pp. 9–27, Butterworths, London, 1973.Google Scholar
  80. 78.
    Ho, H. C., Nasopharyngeal carcinoma in Hong Kong, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 58–63, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  81. 79.
    Ho, J. H. C., The natural history and treatment of nasopharyngeal carcinoma (NPC), in: Oncology, Vol. 4 (Proceedings of the 10th International Cancer Congress) (R. Lee-Clark, R. W. Cumley, J. E. Mccay, and M. Copeland, eds.). pp. 1–14, Year Book Medical Publishers, Chicago, 1970.Google Scholar
  82. 80.
    Ho, H. C., Incidence of nasopharyngeal cancer in Hong Kong, UICC Bulletin, Cancer 9 (2): 5 (1971).Google Scholar
  83. 81.
    Ho, J. H. C., Genetic and environmental factors in nasopharyngeal carcinoma, in: Recent Advances in Human Tumor Virology and Immunology (Proceedings of the First International Cancer Symposium of the Princess Takamatsu Cancer Research Fund) (W. Nakahara, K. Nishioka, T. Hirayama, and Y. ITO, eds.), pp. 275–295, University of Tokyo Press, Tokyo, 1971.Google Scholar
  84. 82.
    Ho, J. H. C., Nasopharyngeal carcinoma (NPC), in: Advances in Cancer Research (G. Klein, S. Weinhouse, and A. Haddow, eds.), pp. 57–92, Academic Press, New York and London, 1972.Google Scholar
  85. 83.
    Ho, H. C., Radiologic diagnosis of nasopharyngeal carcinoma with special reference to its spread through the base of skull, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 238–246, UICC Monograph Series, Vol. 1, Medical Examination Publishing Co., New York, 1972.Google Scholar
  86. 84.
    Ho, H. C., Head and neck-Radiologic diagnosis, J. Am. Med. Assoc. 220: 396 (1972).Google Scholar
  87. 85.
    Ho, H. C., Current knowledge of the epidemiology of nasopharyngeal carcinoma-A review, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. De-Thé, and L. N. Payne, eds.), pp. 357–366, IARC Scientific Publication No. 2, Lyon, France, 1972.Google Scholar
  88. 86.
    Ho, H. C., Epidemiology of nasopharyngeal carcinoma (NPC), in: Proceedings of the 1st Asian Cancer Conference, Shima and Tokyo, September 22–25, 1973.Google Scholar
  89. 87.
    Ho, H. C., Epidemiology of nasopharyngeal cardnoma, J. R. Coll. Surg. Edinburgh 20: 223–235 (1975).Google Scholar
  90. 88.
    Ho, J. H. C., Ng, M. H., Kwan, H. C., and Chan, J. C. W., Epstein-Barr virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma, Br. J. Cancer 34: 655–660 (1976).PubMedGoogle Scholar
  91. 89.
    Ho, H. C., Ng, M. H., and Kwan, H. C., IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients, Br. J. Cancer 35: 888–890 (1977).PubMedGoogle Scholar
  92. 90.
    Ho, J. H. C., An epidemiologic and clinical study of nasopharyngeal carcinoma, Int. J. Radiat. Oncol. Biol. Phys. 4: 181–198 (1978).Google Scholar
  93. 91.
    Ho, H. C., Kwan, H. C., and Ng, M. H., Immunohistochemistry of local immunoglobulin production in nasopharyngeal carcinoma, Br. J. Cancer 37: 514–519 (1978).PubMedGoogle Scholar
  94. 92.
    Ho, H. C., Kwan, H. C., Ng, M. H., and De-Thé, G., Serum IgA antibodies to Epstein-Barr virus capsid antigen preceding symptoms of nasopharyngeal carcinoma, Lancet 1: 436–437 (1978).PubMedGoogle Scholar
  95. 93.
    Ho, J. H. C., Huang, D. P., and Fong, Y. Y., Salted fish and nasopharyngeal carcinoma in southern Chinese, Lancet 1: 626 (1978).Google Scholar
  96. 94.
    Hu, C. H., and Yang, C., A decade of progress in morphologic pathology, Chin. Med. J. 79: 409–422 (1959).PubMedGoogle Scholar
  97. 95.
    Huang, D. P., Ho, J. H. C., Henle, W., and Henle, G., Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies, Int. J. Cancer 14: 580–588 (1974).PubMedGoogle Scholar
  98. 96.
    Huang, D. P., Gough, T., and Ho, J. H. C., Analysis for volatile nitrosamines of salt-preserved foodstuffs traditionally consumed by southern Chinese, in: Nasopharyngeal Carcinoma: Etiology and Control (G. De-Thé and Y. ITo, eds.), pp. 309–314, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  99. 97.
    Huang, D. P., Saw, D., Teoh, T. B., and Ho, J. H. C., Carcinomas in rats fed with Cantonese salted marine fish, in: Nasopharyngeal Carcinoma: Etiology and Control (G. De-Thé and Y. ITO, eds.), pp. 315–328, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  100. 98.
    Huebner, R. J., and Todaro, G. T., Oncogenesis of RNA tumor viruses as determinants of cancer, Proc. Natl. Acad. Sci. U.S.A. 64: 1087–1094 (1969).PubMedGoogle Scholar
  101. 99.
    International Agency For Research On Cancer (Iarc), Cancer Incidence in Five Continents, Vol. III (J. Waterhouse, C. S. Muir, P. Correa, and G. Powell, eds.), IARC Scientific Publication No. 15, Lyon, France, 1976.Google Scholar
  102. 100.
    International Agency For Research On Cancer (Iarc), Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ and Y. ITo, eds.), IARC Scientific Publication No. 20, Lyon, France, 1978.Google Scholar
  103. 101.
    International Agency For Research On Cancer (Iarc), Annual Report, pp. 75–76, IARC, Lyon, France, 1978.Google Scholar
  104. 102.
    International Union Against Cancer Union International Contre LE Cancer (Uicc)J, Cancer of the Nasopharynx, Monograph Series, Vol. 1 ( C. S. Muir and K. Shanmugaratnam, eds.), Munksgaard, Copenhagen, 1967.Google Scholar
  105. 103.
    Jondal, M., and Klein, G., Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies, Biomedicine 23: 163–165 (1975).PubMedGoogle Scholar
  106. 104.
    Jung, P. F., and Yu, C., Nasopharyngeal cancer in China, Postgrad. Med. 33: A77 - A82 (1963).Google Scholar
  107. 105.
    King, H., and Haenszel, K., Cancer mortality among foreign and native-born Chinese in the United States, J. Chron. Dis. 26: 623–646 (1972).Google Scholar
  108. 106.
    Kirk, R. L., Blake, N. M., Serjeantson, S., Simons, M. J., and CHAN, S. H., Genetic components in susceptibility to nasopharyngeal carcinoma, in: Naso-pharyngeal Carcinoma: Etiology and Control (G. De-Thé and Y. ITo, eds.), pp. 283–297, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  109. 107.
    Klein, G., Clifford, P., Klein, E., and Stjernswärd, J., Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction, Proc. Natl. Acad. Sci. U.S.A. 55: 1628–1635 (1966).PubMedGoogle Scholar
  110. 108.
    Klein, G., Pearson, G., Henle, G., Henle, W., Diehl, V., and Niederman, J. C., Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumour cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus, J. Exp. Med. 128: 1011–1020 (1968).PubMedGoogle Scholar
  111. 109.
    Klein, G., EBV associated membrane antigens, in: Oncogenesis and Herpesviruses (P. M. Bigcs, G. De-Thé, and L. N. Payne, eds.), pp. 295–301, IARC Scientific Publication No. 2, Lyon, France, 1972.Google Scholar
  112. 110.
    Klein, G., The Epstein-Barr virus, in: The Herpesviruses (A. Kaplan, ed.), pp. 521–555, Academic Press, New York, 1973.Google Scholar
  113. 111.
    Klein, G., Giovanella, B. C., Lindahl, T., Fialkow, P. J., Singh, S., and Stehlin, J., Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with anaplastic carcinoma of the nasopharynx, Proc. Natl. Acad. Sci. U.S.A. 71: 4737–4741 (1974).PubMedGoogle Scholar
  114. 112.
    Klein, G., and Vonka, V., Relationship between the Epstein-Barr virus (EBV) determined complement fixing antigen and the nuclear antigen (EBNA) detected by anti-complement fluorescence, Int. J. Cancer 53: 1645–1646 (1974).Google Scholar
  115. 113.
    Klein, G., Viral Oncology, Raven Press, New York, 1979.Google Scholar
  116. 114.
    Kmet, J., and Mahboubi, E., Esophageal cancer in the Gaspian littoral of Iran: Initial studies, Science 175: 846–853 (1972).PubMedGoogle Scholar
  117. 115.
    Krogman, W. M., The skeletal and dental pathology of an early Iranian site, Bull. Hist. Med. 8: 28–48 (1940).Google Scholar
  118. 116.
    Laufs, R., Immunisation of marmoset monkeys with a killed oncogenic herpesvirus, Nature (London) 249: 571–572 (1974).PubMedGoogle Scholar
  119. 117.
    Lemaigre, G., Diebold, J., Temmim, L., Arseniev, L., Lecharpentier, Y., Allouache, A., Delaitre, B., and Abelanet, R., Carcinome du nasopharynx chez les sujets jeunes-Étude clinique, anatomique et ultra-structurale de 50 cas observés dans l’est algérien, Nouv. Presse Med. 6: 3509–3513 (1977).PubMedGoogle Scholar
  120. 118.
    Lemon, S. M., Hutt, L. M., Shaw, J., Li, J. L., and Pagano, J., Replication of EBV in epithelial cells during infectious mononucleosis, Nature (London) 268: 268–270 (1977).PubMedGoogle Scholar
  121. 119.
    Lenoir, G., Martin-Berthelon, M. C., Favre, M. C., and DE-THÉ, G., Characterization of EBV antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with EBNA, J. Virol. 17: 672–674 (1976).PubMedGoogle Scholar
  122. 120.
    Levine, P., Cho, B., Connelly, R., de Vita, C., Ber-Ard, C., O’CONOR, G., and Dorhman, R., The American Burkitt’s lymphoma registry: A progress report, Ann. Intern. Med. 83: 82–83 (1975).Google Scholar
  123. 121.
    Levine, P. H., De-Thé, G., Brugere, J., Schwaab, G., Mourali, N., Heberman, R. B., Ambrosioni, J. C., and Revol, P., Immunity to antigens associated with a cell line derived from nasopharyngeal carcinoma (NPC) in non-Chinese NPC patients, Int. J. Cancer 17: 155–160 (1976).PubMedGoogle Scholar
  124. 122.
    Liang, P. C., Studies on nasopharyngeal carcinoma in the Chinese: Statistical and laboratory investigations, Chin. Med. J. 83: 373–390 (1964).PubMedGoogle Scholar
  125. 123.
    Lilly, F., The inheritance of susceptibility of the Gross leukemia virus in mice, Genetics 53: 529–539 (1966).PubMedGoogle Scholar
  126. 124.
    Lilly, F., Mouse leukemia: A model of a multiple-gene disease J. Natl. Cancer Inst. 49: 927–934 (1972).PubMedGoogle Scholar
  127. 125.
    Lin, T. M., Hsu, M. M., Cheng, K. P., Chiang, T. C., Jung, P. F., and Hirayama, T., Morbidity and mortality of cancer of the nasopharynx in Taiwan, Gann Monogr. 10: 137–144 (1971).Google Scholar
  128. 126.
    Lin, T. M., Chen, K. P., Lin, C. C., Hsu, M. M., Tu, S. M., Chiang, T. C., Jung, P. F., and Hirayama, T., Retrospective study on nasopharyngeal carcinoma, J. Natl. Cancer Inst. 51: 1403–1408 (1975).Google Scholar
  129. 127.
    Linsell, C. A., Cancer in Kenya, in: Cancer in Africa (P. Clifford, C. A. Linsell, and G. L. Timms, eds.), pp. 7–12, East African Publiching House, Nairobi, 1968.Google Scholar
  130. 128.
    Mcdevitt, H. O., and Bodmer, W. J., HL-A, immune response genes, and disease: Occasional survey, Lancet 1: 1269–1275 (1974).PubMedGoogle Scholar
  131. 129.
    Michaux, L., Carcinome de base du crâne, Cited by Godtfredson, E., Ophthalmologic and neurologic symptoms of malignant nasopharyngeal tumours: Clinical study comprising 454 cases, with special reference to histo-pathology and possibility of earlier recognition, Acta Psychiatr. Scand. Suppl. 34: 1–323 (1944).Google Scholar
  132. 130.
    Miller, G., Niederman, J. C., and Still, D. A., Infectious mononucleosis: Appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines, J. Infect. Dis. 125: 403–406 (1972).PubMedGoogle Scholar
  133. 131.
    Muir, C. S., and Oakley, W. F., Nasopharyngeal carcinoma in Sarawak (Borneo), J. Laryngol. 81: 197–207 (1967).Google Scholar
  134. 132.
    Muir, C. S., and Shanmugaratnam, K., The incidence of nasopharyngeal cancer in Singapore, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 47–53, UICC Monograph Series, No. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  135. 133.
    Muir, C. S., Nasopharyngeal carcinoma in non-Chinese populations with special reference to South East Asia and Africa, Int. J. Cancer 8: 351–363 (1971).PubMedGoogle Scholar
  136. 134.
    Muir, C. S., Nasopharyngeal carcinoma in non-Chinese populations, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. De-Thé, and L. N. Payne, eds.), pp. 367–371, IARC Scientific Publication No. 2, Lyon, France, 1972.Google Scholar
  137. 135.
    Muir, C. S., Geographical differences in cancer patterns, in: Host Environment Interactions in the Etiology of Cancer in Men (R. Doll and I. Vodopija, eds.), pp. 1–13, IARC Scientific Publication No. 7, IARC, Lyon, France, 1973.Google Scholar
  138. 136.
    Nevo, S., Meyer, W., and Altman, M., Carcinoma of nasopharynx in twins, Cancer 28: 807–809 (1971).PubMedGoogle Scholar
  139. 137.
    Niederman, J. C., and Evans, A. S., Infectious mononucleosis, in: Serological Epidemiology, pp. 119–132, Academic Press, New York, 1973.Google Scholar
  140. 138.
    Nielsen, N. H., Mikkelsen, F., and Hart-Hansen, J. P., Nasopharyngeal cancer in Greenland: Incidence in an arctic Eskimo population, Acta Pathol. Microbiol. Scand. Sect. A 85: 850–858 (1977).Google Scholar
  141. 139.
    Nilsson, K., Klein, G., Henle, G., and Henle, W., The role of EBV in the establishment of lymphoblastoid cell lines from adult and foetal lymphoid tissue, in: Oncogenesis and Herpesviruses (P. M. BIGGS, G. De-Thé, and L. N. Payne, eds.), pp. 285–290, IARC Scientific Publication No. 2, Lyon, France, 1972.Google Scholar
  142. 140.
    Nonoyama, M., and Pagano, J. S., Homology between Epstein-Barr viruses DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics, Nature (London) 242: 44–47 (1973).Google Scholar
  143. 141.
    O’conor, G. T., Persistent immunological stimulation as a factor in oncogenesis with special reference to Burkitt’s tumour, Am. J. Med. 48: 279–285 (1970).Google Scholar
  144. 142.
    Old, L. J., Boyse, E. A., Oettgen, H. F., De-Harven, E., Geering, G., Williamson, E., and Clifford, P., Precipitation antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells, Proc. Natl. Acad. Sci. U.S.A. 56: 1699–1704 (1966).PubMedGoogle Scholar
  145. 143.
    Pagano, J. S., Huang, C. H., and Levine, P., Absence of Epstein-Barr viral DNA in American Burkitt’s lymphoma, N. Engl. J. Med. 289: 1395–1399 (1973).PubMedGoogle Scholar
  146. 144.
    Pagano, J. S., Huang, C. H., Klein, G., De-Thé, G., Shanmugaratnam, K., Simons, M. J., and Yan, C. S., Homology of Epstein-Barr viral DNA in naso-pharyngeal carcinoma from Kenya, Taiwan, Singapore and Tunis, in: Oncogenesis and Herpesviruses II (G. De-Thé, M. A. Epstein, and H. Zur Hausen, eds.), pp. 191–193, IARC Scientific Publication No. 11, Vol. 2, IARC, Lyon, France, 1975.Google Scholar
  147. 145.
    Pearson, G. R., Coates, H. L., Needl, H. B., Levine, P., Ablashi, D., and Easton, J., Clinical evaluation of EBV serology in American patients with naso-pharyngeal carcinoma, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ and Y. ITO, eds.), pp. 439–448, IARC Scientific Publication No. 20, Lyon, France, 1978.Google Scholar
  148. 146.
    Pereira, M. S., Field, A. M., Blake, J. M., Rodgers, F. G., and Bailey, L. A., Evidence for oral excretion of EB virus in infectious mononucleosis, Lancet 1: 710–711 (1972).PubMedGoogle Scholar
  149. 147.
    Peto, R., Epidemiology, multistage models, and short-term mutagenicity tests, in: Origins of Human Cancer (H. Hiatt, J. D. Watson, and J. A. Winsten, eds.), pp. 1403–1428, Cold Spring Harbor Conferences on Cell Proliferation, Vol. 4, Book C, Cold Spring Harbor Laboratory Publ., Cold Spring Harbor, New York, 1977.Google Scholar
  150. 148.
    Polunin, I., The ways of life of people with high rates of nasopharyngeal carcinoma, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 106–111, IUCC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  151. 149.
    Reedman, B. M., Pope, J. H., and Moss, D. J., Identity of the soluble EBV associated antigens of human lymphoid cell lines, Int. J. Cancer 9: 172–181 (1972).PubMedGoogle Scholar
  152. 150.
    Reedman, B. M., and Klein, G., Cellular localization of an Epstein-Barr virus (EBV) associated complement-fixing antigen in producer and nonproducer lymphoblastoid cell lines, Int. J. Cancer 11: 499–520 (1973).PubMedGoogle Scholar
  153. 151.
    Reedman, B. M., Klein, G., Pope, J. H., Walters, M. K., Hilgers, J., Smith, S., and Johansson, B., Epstein-Barr virus associated complement fixing and nuclear antigens in Burkitt’s lymphoma biopsies, Int. J. Cancer 13: 755–763 (1974).PubMedGoogle Scholar
  154. 152.
    Saad, A., Observations on nasopharyngeal carcinoma in the Sudan, in: Cancer in Africa (C. A. Linsell and G. L. Limms, eds.), pp. 281–285, East African Publishing House, Nairobi, 1968.Google Scholar
  155. 153.
    Schmauz, R., and Templeton, A. C., Nasopharyngeal cancer in Uganda, Cancer 29: 610–621 (1972).PubMedGoogle Scholar
  156. 153a.
    Scott, G. C., and Atkinson, L., Demographic features of the Chinese population in Australia and the relative prevalence of nasopharyngeal cancer among Caucasians and Chinese, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 64–72, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  157. 154.
    Shanmugaratnam, K., Nasopharyngeal carcinoma in Asia, in: Racial and Geographical Factors in Tumour Incidence (A. A. Shivas, ed.), pp. 169–188, Pfizer Medical Monograph, Vol. 2, Edinburgh University Press, Edinburgh, 1967.Google Scholar
  158. 155.
    Shanmugaratnam, K., and Muir, C. S., Nasopharyngeal carcinoma: Origin and structure, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 153–162, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  159. 156.
    Shanmugaratnam, K., and Higginson, J., Aetiology of nasopharyngcal carcinoma: Report on a retrospective survey in Singapore, in: Cancer of the Nasopharynx (C. S. MUIR and K. Shanmugaratnam, eds.), pp. 130–137, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  160. 157.
    Shanmugaratnam, K., and Tye, C. Y., A study of nasopharyngeal cancer among Singapore Chinese with special reference to migrant status and specific community (dialect group), J. Chron. Dis. 23: 433–441 (1970).PubMedGoogle Scholar
  161. 158.
    Shanmugaratnam, K., Studies on the etiology of nasopharyngeal carcinoma, Int. Rev. Exp. Pathol. 10: 361–413 (1971).PubMedGoogle Scholar
  162. 159.
    Shanmugaratnam, K., Cancer in Singapore—Ethnic and dialect group variations in cancer incidence, Singapore Med. J. 14: 68–81 (1973).Google Scholar
  163. 160.
    Shanmugaratnam, K., and Wee, A., “Dialect group” variations in cancer incidence among Chinese in Singapore, in: Host Environment Interaction in the Etiology of Cancer in Humans (R. Don and I. Bodopija, eds.), pp. 67–82, IARC Scientific Publication No. 7, Lyon, France, 1973.Google Scholar
  164. 161.
    Shanmugaratnam, K., Tye, C. Y., Goh, E. H., and Chia, K. B., Etiological factors in nasopharyngeal carcinoma: A hospital-based, retrospective case–control questionnaire study, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ and Y. Iro, eds.), pp. 199–212, IARD Scientific Publication No. 20, Lyon, France, 1978.Google Scholar
  165. 162.
    Simons, M. J., Wee, G. B., Day, N. E., De-Thé, G., Morris, P. J., and Shanmugaratnam, K., Immunogenetic aspects of nasopharyngeal carcinoma. I. Differences in HL-A antigen profiles between patients and comparison groups, Int. J. Cancer 13: 122–134 (1974).PubMedGoogle Scholar
  166. 163.
    Simons, M. J., Day, N. E., Wee, G. B., Shanmugaratnam, K., Ho, H. C., Wong, S. H., Ti, T. K., Yong, N. K., Darmalingam, S., and De-Thé, G., Nasopharyngeal carcinoma. V. Immunogenetic studies of South East Asian ethnic groups with high and low risk for the tumor, Cancer Res. 34: 1192–1195 (1974).PubMedGoogle Scholar
  167. 164.
    Simons, M. J., Wee, G. B., Day, N. E., Chan, S. H., Shanmugaratnam, K., and De-Thé, G., Immunogenetic aspects of nasopharyngeal carcinoma (NPC). IV. Probable identification of an HL-A second antigen associated with a high risk for NPC, Lancet 1: 142–143 (1975).PubMedGoogle Scholar
  168. 165.
    Simons, M. J., Day, N. E., Wee, G. B., Chan, S. H., Shanmugaratnam, K., and De-Thé, G., Immunogenetic aspects of nasopharyngeal carcinoma (NPC). III. HL-A type as a genetic marker of NPC predisposition to test the hypothesis that EBV is an aetiologic factor in NPC, in: Oncogenesis and Herpesviruses II (G. De-Thé, M. A. Epstein, and H. Zur Hausen, eds.), pp. 249–258, IARC Scientific Publication No. 11, Vol. 2, IARC, Lyon, France, 1975.Google Scholar
  169. 166.
    Simons, M. J., Wee, G. B., Goh, E. H., Chan, S. H., Shanmugaratnam, K., Day, N. E., and De-Thé, G., Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2), J. Natl. Cancer Inst. 57: 977–980 (1976).PubMedGoogle Scholar
  170. 167.
    Simons, M. J., Chan, S. H., Wee, G. B., Shanmugaratnam, K., Goh, E. H., Ho, J. H. C., Chau, J. C. W., Darmalingam, S., Prasad, U., Betuel, H., Day, N. E., and De-Thé, G., Nasopharyngeal carcinoma and histocompatibility antigens, in: Nasopharyngeal Carcinoma: Etiology and Control (G. De-Thé and Y. ITo, eds.), pp. 271–282, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  171. 168.
    Smith, G. E., and Dawson, W. R., in: Egyptian Mummies, p. 157, Allen and Unwin, London, 1924.Google Scholar
  172. 169.
    Sohier, R., and De-Thé, G., Fixation du complément avec un antigène soluble: Différences d’activité importantes entre les sérums de lymphoma de Burkitt, de cancer du rhinopharynx et de mononucléose infectieuse, C. R. Acad. Sci. 273: 121–124 (1971).Google Scholar
  173. 170.
    Sohier, R., and De-Thé, G., Evolution of complement-fixing antibody titers with the development of Burkitt’s lymphoma, Int. J. Cancer 9: 524–528 (1972).PubMedGoogle Scholar
  174. 171.
    Svoboda, D. J., Kirchner, K. R., and Shanmugaratnam, K., Ultrastructure of nasopharyngeal carcinomas in American and Chinese patients: An application of electron microscopy to geographic pathology, Exp. Mol. Pathol. 4: 189–204 (1965).Google Scholar
  175. 172.
    Svoboda, D. J., Kirchner, K. R., and Shanmugaratnam, K., The fine structure of nasopharyngeal carcinoma, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 163–171, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1%7.Google Scholar
  176. 173.
    Terracini, B., Magee, P. N., and Barnes, J. M., Hepatic pathology on low dietary levels of dimethylni-trosamine, Br. J. Cancer 21: 599–565 (1967).Google Scholar
  177. 174.
    Trumper, P. A., Epstein, M. A., Giovanella, G. C., and Finerty, S., Isolation of infectious EB virus from epithelial tumor cells of nasopharyngeal carcinoma, Int. J. Cancer 20: 655–662 (1977).PubMedGoogle Scholar
  178. 175.
    Union International Contre Le Cancer, Cancer Incidence in Five Continents-Technical Report (R. Doll, P. Payne, and J. Waterhouse, eds.), UICC, Geneva, 1966.Google Scholar
  179. 176.
    Union International Contre Le Cancer, Cancer Incidence in Five Continents, Vol. 2 ( R. Doll, C. Muir, and J. Waterhouse, eds.), UICC, Geneva, 1970.Google Scholar
  180. 177.
    Vonka, V., Benyesh-Melnick, M., Lewis, R. T., and Wimberly, I., Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines, Arch. Gesamte Virusforsch. 31: 113–124 (1970).PubMedGoogle Scholar
  181. 178.
    Vonka, V., Vlchova, I., Zavadova, H., Kouba, K., Lasovska, J., and Duben, J., Antibodies to EB virus capsid antigen and to soluble antigen of lymphoblastoid cell in infectious mononucleosis patients, Int. J. Cancer 9: 529–535 (1972).PubMedGoogle Scholar
  182. 179.
    Vuillaume, M., and De-Thé, G., Nasopharyngeal carcinoma. III. Ultrastructure of different growths leading to lymphoblastoid Transformation in vitro, J. Natl. Cancer Inst. 51: 67–80 (1973).PubMedGoogle Scholar
  183. 180.
    Walshe, R. J., The physical anthropology of races with a high incidence of nasopharyngeal cancer, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 112–118, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  184. 181.
    Walters, M. K., and Pope, J. H., Studies of the EB virus-related antigens of human leukocyte cell lines, Int. J. Cancer 8: 32–40 (1971).PubMedGoogle Scholar
  185. 182.
    Wara, W. M., Wara, D. W., Phillips, T. L., and Ammahh, A., Elevated IgA in carcinoma of the nasopharynx, Cancer 35: 1313–1315 (1975).PubMedGoogle Scholar
  186. 183.
    Wells, C., Ancient Egyptian pathology, J. Laryngol. 77: 261–265 (1963).Google Scholar
  187. 184.
    Wells, C., Two mediaeval cases of malignant disease, Br. Med. J. 1: 1611–1612 (1964).PubMedGoogle Scholar
  188. 185.
    Williams, E. H., Day, N. E., and Geser, A., Seasonal variation in onset of Burkitt’s lymphoma in the West Nile district of Uganda, Lancet 2: 19–22 (1974).PubMedGoogle Scholar
  189. 186.
    Williams, E. H., Andde-Thé, G., Familial aggregation in nasopharyngeal carcinoma (letter to the editor), Lancet 2: 295 (1974).PubMedGoogle Scholar
  190. 187.
    Wolf, H., ZUR Hausen, H., and Becker, V., EB viral genomes in epithelial nasopharyngeal carcinoma cells, Nature (London) New Biol. 244: 245–257 (1973).Google Scholar
  191. 188.
    World Health Organization, Mortality from Malignant Neoplasms 1955–1965, Geneva, 1970.Google Scholar
  192. 189.
    World Health Organization (Who), Histological Typing of Upper Respiratory Tract Tumours: International Classification of Tumours, No. 19 ( K. Shanmugaratnam and L. H. Sobin, eds. ), 1978.Google Scholar
  193. 190.
    Worth, R. M., and Valentine, R., Nasopharyngeal carcinoma in New South Wales, Australia, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 73–76, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  194. 191.
    Wu, C. H. (ed.), The Encyclopaedia of Chinese Medical Terms, Vol. 1, p. 756, Commercial Press, Shanghai, 1921 (in Chinese).Google Scholar
  195. 192.
    Yata, J., Desgranges, C., De-Thé, G., and Tachibana, T., Lymphocytes in infectious mononucleosis: Properties of atypical cells and origin of the lymphoblastoid lines, Biomedicine 19: 479–483 (1973).PubMedGoogle Scholar
  196. 193.
    Yata, J., Desgranges, C., Nakagawa, T., Favre, M. C., and De-Thé, G., Lymphoblastoid transformation and kinetics in the appearance of Epstein-Barr viral nuclear antigen (EBNA) in cord blood B cells by Epstein-Barr virus infection, Int. J. Cancer 15: 377–384 (1975).PubMedGoogle Scholar
  197. 194.
    Yata, J., Desgranges, C., De-Thé, G., and Tachibana, T., Nasopharyngeal carcinoma. VII. Lymphocyte subpopulations in the blood and tumour tissue, Biomedicine 21: 244–250 (1974).PubMedGoogle Scholar
  198. 195.
    Yeh, S., Histology of nasopharyngeal cancer, in: Cancer of the Nasopharynx (C. S. Muir and K. Shanmugaratnam, eds.), pp. 147–152, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  199. 196.
    Yun, I. S., A statistical study of tumours among Koreans, Cancer Res. 9: 370–371 (1949).PubMedGoogle Scholar
  200. 197.
    Zaouche, A., Lestumeurs malignes de la sphère ORL en Tunisie: A propos des 644 tumeurs des voies aero-digestives superieures à l’Institut National de Carcinologie de Tunis due 1.10.67 au 15.8. 69, Thesis, Paris, 1970.Google Scholar
  201. 198.
    Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., and Santesson, L., EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx, Nature (London) 228: 1056–1058 (1970).PubMedGoogle Scholar
  202. 199.
    Zeng Y., Liu Y. X., Liu C. R., Chen S. W., Wei J. N., Zhu J. N., and Zai H. J., Application of immunoenzymatic method and immunoautoradiographic method for the mass survey of nasopharyngeal carcinoma, Intervirology 133: 166–168 (1980).Google Scholar
  203. 200.
    Zeng, Y., Shang, M. and Liu, C. R., Detection of anti Epstein-Barr virus IgA in NPC patients in 8 provinces and cities in China, Chinese Oncology 1, 2 (1979).Google Scholar
  204. 201.
    Zeng, Y., Shen, S., Pi, G., Ma, J. L., Zhang, Q., Zhao, M. G., and Dong, H. J., Application of anti-complement immunoenzymatic method for the detection of EBNA in carcinoma cells and normal epithelial cells from the nasopharynx, in: Nasopharyngeal 652 Chapter 25 • Nasopharyngeal Carcinoma Carcinoma, Cancer Campaign, Vol. 5, ( Gzundman, E., Kzueger, G., Zundman, E., Kzueger, G. R. F., and Ablashi, D. B., eds.), Gustav Fischer Verlag, Stuttgart, 1981.Google Scholar

Suggested Reading

  1. De-Thé, G., The Chinese epidemiological approach of nasopharyngeal carcinoma research and control, The Yale J. Biol. Med. 54: 33–39 (1981).Google Scholar
  2. De-Thé, G., The Chinese epidemiological approach of nasopharyngeal carcinoma research and control, The Yale J. Biol. Med. 54: 33–39 (1981).Google Scholar
  3. De-Thé, G. and Yto, X., eds., Nasopharyngeal Carcinoma: Etiology and Control. IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  4. Gzundman, E., Kzueger, G., Zundman, E., Kzueger, G. R. F., and Ablashi, D. V., eds. Nasopharyngeal Carcinoma, Cancer Campaign, Vol. 5, Gustav Fischer Verlag, Stuttgart, 1981.Google Scholar
  5. Mum, C. S. Nasopharyngeal carcinoma in non Chinese populations with special reference to South East Asia and Africa, Int. J. Cancer, 8: 351–363 (1971).Google Scholar
  6. Muir, C. S., and Shanmugaratnam, K., eds., Cancer of the Nasopharynx, UICC Monograph Series, No. 1, Munksgaard, Copenhagen, 1967.Google Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • G. de-Thé
    • 1
  • J. H. C. Ho
    • 2
  • C. S. Muir
    • 3
  1. 1.CNRS, Faculty of Medicine A. CarrelLyon and Cancer Institute—CNRSVillejuifFrance
  2. 2.Institute of Radiology and OncologyQueen Elizabeth HospitalKowloon, Hong KongChina
  3. 3.International Agency for Research on CancerLyonFrance

Personalised recommendations